Switch theme
Sign up to access all valuation multiples
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.
2007
35.1K+
LTM Revenue $19.1B
LTM EBITDA $5.4B
$55.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Reckitt has a last 12-month revenue (LTM) of $19.1B and a last 12-month EBITDA of $5.4B.
In the most recent fiscal year, Reckitt achieved revenue of $19.0B and an EBITDA of $4.0B.
Reckitt expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Reckitt valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $19.1B | XXX | $19.0B | XXX | XXX | XXX |
| Gross Profit | $11.5B | XXX | $11.5B | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 61% | XXX | XXX | XXX |
| EBITDA | $5.4B | XXX | $4.0B | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 21% | XXX | XXX | XXX |
| EBIT | $4.7B | XXX | $4.6B | XXX | XXX | XXX |
| EBIT Margin | 25% | XXX | 24% | XXX | XXX | XXX |
| Net Profit | $3.2B | XXX | $1.9B | XXX | XXX | XXX |
| Net Margin | 17% | XXX | 10% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $10.2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Reckitt's stock price is GBP 49 (or $66).
Reckitt has current market cap of GBP 33.7B (or $45.2B), and EV of GBP 41.6B (or $55.8B).
See Reckitt trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $55.8B | $45.2B | XXX | XXX | XXX | XXX | $4.66 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Reckitt has market cap of $45.2B and EV of $55.8B.
Reckitt's trades at 2.9x EV/Revenue multiple, and 14.1x EV/EBITDA.
Equity research analysts estimate Reckitt's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Reckitt has a P/E ratio of 14.0x.
See valuation multiples for Reckitt and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $45.2B | XXX | $45.2B | XXX | XXX | XXX |
| EV (current) | $55.8B | XXX | $55.8B | XXX | XXX | XXX |
| EV/Revenue | 2.9x | XXX | 2.9x | XXX | XXX | XXX |
| EV/EBITDA | 10.3x | XXX | 14.1x | XXX | XXX | XXX |
| EV/EBIT | 11.9x | XXX | 12.1x | XXX | XXX | XXX |
| EV/Gross Profit | 4.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 14.0x | XXX | 23.6x | XXX | XXX | XXX |
| EV/FCF | 19.3x | XXX | 18.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialReckitt's last 12 month revenue growth is 2%
Reckitt's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Reckitt's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Reckitt's rule of X is 32% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Reckitt and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 21% | XXX | XXX | XXX |
| EBITDA Growth | -1% | XXX | 11% | XXX | XXX | XXX |
| Rule of 40 | 23% | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 25% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 36% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Reckitt acquired XXX companies to date.
Last acquisition by Reckitt was XXXXXXXX, XXXXX XXXXX XXXXXX . Reckitt acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Reckitt founded? | Reckitt was founded in 2007. |
| Where is Reckitt headquartered? | Reckitt is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Reckitt have? | As of today, Reckitt has 35.1K+ employees. |
| Who is the CEO of Reckitt? | Reckitt's CEO is Mr. Kris Licht. |
| Is Reckitt publicy listed? | Yes, Reckitt is a public company listed on LON. |
| What is the stock symbol of Reckitt? | Reckitt trades under RKT ticker. |
| When did Reckitt go public? | Reckitt went public in 2007. |
| Who are competitors of Reckitt? | Similar companies to Reckitt include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Reckitt? | Reckitt's current market cap is $45.2B |
| What is the current revenue of Reckitt? | Reckitt's last 12 months revenue is $19.1B. |
| What is the current revenue growth of Reckitt? | Reckitt revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Reckitt? | Current revenue multiple of Reckitt is 2.9x. |
| Is Reckitt profitable? | Yes, Reckitt is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Reckitt? | Reckitt's last 12 months EBITDA is $5.4B. |
| What is Reckitt's EBITDA margin? | Reckitt's last 12 months EBITDA margin is 28%. |
| What is the current EV/EBITDA multiple of Reckitt? | Current EBITDA multiple of Reckitt is 10.3x. |
| What is the current FCF of Reckitt? | Reckitt's last 12 months FCF is $2.9B. |
| What is Reckitt's FCF margin? | Reckitt's last 12 months FCF margin is 15%. |
| What is the current EV/FCF multiple of Reckitt? | Current FCF multiple of Reckitt is 19.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
